RE:RE:Interesting detailed study of 21 cannabis companiesI 100% agree that based on future revenue and growth potential this company is undervalued. But there is a reason they are undervalued and it has to do with several of the fiancial transaction the company made including issuing extreamly cheap shares and warrents to insiders and also agreeing to a financing deal that including allowing the large amounts of the shares to be shorted.
That being said the company has also made a lot of good deals and does appear to be set up to generate very healthly revenues and profits in 2020 and beyond.
I bought back in yesterday at $0.80 for about 25% of what I sold at $0.88 after they released thier earnings. My guess is they stay undervalued for another couple quarters and I would not be surprised if they dropped into the $0.70s after there next earnings release within a month, so I may add more later if the price drops further.